Metraipolis › archive › dc_caf09271d677

Gastrointestinal toxicity of targeted cancer therapies in the United States: Clinicopathologic patterns, FDA safety frameworks, and implications for national… — Europe PMC PMID:41676232

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41676232
DOI
10.18632/oncoscience.643
License (as archived)
solo-consultazione
Archived
2026-11-06T01:33:11.683Z
SHA-256 of the archived text
aef776d5e493005e12b0bbe951e930a6edc5629a1291e58b62f03bbe3045787b
Stable URL of this page
https://metraipolis.com/documento/dc_caf09271d677

How to cite

Gastrointestinal toxicity of targeted cancer therapies in the United States: Clinicopathologic patterns, FDA safety frameworks, and implications for national… — Europe PMC PMID:41676232 — Europe PMC (en), https://europepmc.org/article/MED/41676232 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_caf09271d677 (Metraipolis archive dc_caf09271d677, sha256 aef776d5e493005e12b0bbe951e930a6edc5629a1291e58b62f03bbe3045787b)
BibTeX
@misc{dccaf09271d677,
  title = {Gastrointestinal toxicity of targeted cancer therapies in the United States: Clinicopathologic patterns, FDA safety frameworks, and implications for national… — Europe PMC PMID:41676232},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41676232},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_caf09271d677; sha256 aef776d5e493005e12b0bbe951e930a6edc5629a1291e58b62f03bbe3045787b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41676232. Agents can read the archived copy with the MCP tool read_document.